JP2024532784A5 - - Google Patents
Info
- Publication number
- JP2024532784A5 JP2024532784A5 JP2024508548A JP2024508548A JP2024532784A5 JP 2024532784 A5 JP2024532784 A5 JP 2024532784A5 JP 2024508548 A JP2024508548 A JP 2024508548A JP 2024508548 A JP2024508548 A JP 2024508548A JP 2024532784 A5 JP2024532784 A5 JP 2024532784A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- rna
- nos
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232723P | 2021-08-13 | 2021-08-13 | |
| US63/232,723 | 2021-08-13 | ||
| PCT/US2022/074941 WO2023019269A2 (en) | 2021-08-13 | 2022-08-12 | Novel omni 115, 124, 127, 144-149, 159, 218, 237, 248, 251-253 and 259 crispr nucleases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532784A JP2024532784A (ja) | 2024-09-10 |
| JP2024532784A5 true JP2024532784A5 (enExample) | 2025-08-20 |
Family
ID=85201029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508548A Pending JP2024532784A (ja) | 2021-08-13 | 2022-08-12 | 新規なｏｍｎｉ－１１５、１２４、１２７、１４４～１４９、１５９、２１８、２３７、２４８、２５１～２５３及び２５９ｃｒｉｓｐｒヌクレアーゼ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240376453A1 (enExample) |
| EP (1) | EP4384610A4 (enExample) |
| JP (1) | JP2024532784A (enExample) |
| KR (1) | KR20240045285A (enExample) |
| CN (1) | CN118103503A (enExample) |
| AU (1) | AU2022325958A1 (enExample) |
| CA (1) | CA3228373A1 (enExample) |
| IL (1) | IL310732A (enExample) |
| WO (1) | WO2023019269A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024506608A (ja) | 2021-02-08 | 2024-02-14 | エメンドバイオ・インコーポレイテッド | Ｏｍｎｉ－１０３ ｃｒｉｓｐｒヌクレアーゼ |
| US12091688B2 (en) | 2021-02-08 | 2024-09-17 | Emendobio Inc. | OMNI-103 CRISPR nuclease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018081728A1 (en) * | 2016-10-31 | 2018-05-03 | Emendobio Inc. | Compositions for genome editing |
| SG11201906297QA (en) * | 2017-03-24 | 2019-10-30 | Curevac Ag | Nucleic acids encoding crispr-associated proteins and uses thereof |
| WO2019165168A1 (en) * | 2018-02-23 | 2019-08-29 | Pioneer Hi-Bred International, Inc. | Novel cas9 orthologs |
| US20220213456A1 (en) * | 2019-04-30 | 2022-07-07 | Emendobio Inc. | Novel omni crispr nucleases |
| WO2021097271A1 (en) * | 2019-11-15 | 2021-05-20 | Assembly Biosciences, Inc. | Compositions comprising bacterial species and methods related thereto |
| EP4259159A4 (en) * | 2020-12-14 | 2025-04-09 | Emendobio Inc. | Biallelic knockout of trac |
| WO2022132765A1 (en) * | 2020-12-14 | 2022-06-23 | Emendobio Inc. | Biallelic knockout of b2m |
-
2022
- 2022-08-12 IL IL310732A patent/IL310732A/en unknown
- 2022-08-12 CA CA3228373A patent/CA3228373A1/en active Pending
- 2022-08-12 CN CN202280068825.XA patent/CN118103503A/zh active Pending
- 2022-08-12 KR KR1020247008131A patent/KR20240045285A/ko active Pending
- 2022-08-12 WO PCT/US2022/074941 patent/WO2023019269A2/en not_active Ceased
- 2022-08-12 EP EP22856851.5A patent/EP4384610A4/en active Pending
- 2022-08-12 US US18/683,113 patent/US20240376453A1/en active Pending
- 2022-08-12 JP JP2024508548A patent/JP2024532784A/ja active Pending
- 2022-08-12 AU AU2022325958A patent/AU2022325958A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9868962B2 (en) | CRISPR hybrid DNA/RNA polynucleotides and methods of use | |
| KR102382772B1 (ko) | 화학적으로 변형된 가이드 rna를 사용하는 고 특이성 게놈 편집 | |
| JP2022531347A5 (enExample) | ||
| CN105886498A (zh) | CRISPR-Cas9特异性敲除人PCSK9基因的方法以及用于特异性靶向PCSK9基因的sgRNA | |
| WO2017181107A2 (en) | Modified cpf1 mrna, modified guide rna, and uses thereof | |
| CN104520429A (zh) | 通过Cas9-crRNA复合物的RNA指导的DNA裂解 | |
| JP2024532784A5 (enExample) | ||
| KR20160089530A (ko) | Ｈｂｖ 및 바이러스 질병 및 질환을 위한 ｃｒｉｓｐｒｃａｓ 시스템 및 조성물의 전달，용도 및 치료적 적용 | |
| JP2016500262A5 (enExample) | ||
| KR20210008179A (ko) | 올리고뉴클레오티드의 생성을 위한 신규한 방법 | |
| JP2023508731A5 (enExample) | ||
| US20250223592A1 (en) | Compositions and methods for circular rna affinity purification | |
| US12435323B2 (en) | Enzymes with RUVC domains | |
| CN113950531A (zh) | 使用m13噬菌体优化环状单链dna | |
| WO2024140987A1 (en) | Rna circularization | |
| WO2014102688A1 (en) | New design matrix for improvement of homology-directed gene targeting | |
| CN105602972B (zh) | 基于CRISPR-Cas9体外改造腺病毒载体的方法 | |
| WO2024003810A1 (en) | Guide rna with chemical modifications | |
| KR102679001B1 (ko) | 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도 | |
| EP4606894A1 (en) | Fusion protein containing cas protein and bacterial toxin and use thereof | |
| Weisbach et al. | Multiplexed genome engineering with Cas12a | |
| WO2025140537A1 (en) | Rna circularization | |
| CN110885853A (zh) | 构建多sgRNA表达载体的方法 | |
| JP7621281B2 (ja) | 細菌、肺パスツレラ菌（Ｐａｓｔｅｕｒｅｌｌａ ｐｎｅｕｍｏｔｒｏｐｉｃａ）由来のＣａｓ９タンパク質に基づくＤＮＡカット剤 | |
| CN120718906A (zh) | 一种优化的ωRNA及其基因编辑应用 |